E-LIB Suche - Ergebnisse für: Pour, L.

1

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREA..:

van de Donk, N. ; Minnema, M.C. ; van der Holt, B....
HemaSphere. 7 (2023) S2 - p. 4-5 , 2023

Link: https://doi.org/10.1097/..

2

P34 LIGHTHOUSE (OP-108): MELFLUFEN PLUS DARATUMUMAB (DARA) ..:

Mateos, M ; Szarejko, M ; Bila, J...
HemaSphere. 7 (2023) S2 - p. 29-30 , 2023

Link: https://doi.org/10.1097/..

3

PB1974: MULTIVARIATE SPECTRAL BIOTYPING OF EXTRAMEDULLARY M..:

Vlachová, M. ; Gregorová, J. ; Adamová, S....
HemaSphere. 6 (2022) - p. 1847-1848 , 2022

Link: https://doi.org/10.1097/..

4

P967: TUMOR BURDEN AS A CRITICAL PROGNOSTIC FACTOR OF PRIMA..:

Vlachová, M. ; Štork, M. ; Ševčíková, S....
HemaSphere. 6 (2022) - p. 857-858 , 2022

Link: https://doi.org/10.1097/..

5

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS W..:

Maiolino, A ; Hajek, R ; Jelinek, T...
Hematology, Transfusion and Cell Therapy. 43 (2021) - p. S197-S198 , 2021

Link: https://doi.org/10.1016/..

6

Methodology and results of real-world cost-effectiveness of..:

Campioni, M. ; Agirrezabal, I. ; Hajek, R....
The European Journal of Health Economics. 21 (2020) 2 - p. 219-233 , 2020

Link: https://www.jstor.org/st..

7

EFFICACY AND SAFETY OF CARFILZOMIB, DEXAMETHASONE, DARATUMU..:

Leleu, X. ; Beksac, M. ; Chou, T....
Hematology, Transfusion and Cell Therapy. 42 (2020) - p. 257-258 , 2020

Link: https://doi.org/10.1016/..

8

Methodology and results of real-world cost-effectiveness of..:

Campioni, M. ; Agirrezabal, I. ; Hajek, R....
The European Journal of Health Economics. 21 (2019) 2 - p. 219-233 , 2019

Link: https://doi.org/10.1007/..

9

Simplified novel prognostic score for real-life older adult..:

Radocha, J. ; Hájek, R. ; Brožová, L....
Annals of Hematology. 98 (2018) 4 - p. 951-962 , 2018

Link: https://doi.org/10.1007/..

10

Impact of prior treatment on patients with relapsed multipl..:

Moreau, P ; Joshua, D ; Chng, W-J...
Leukemia. 31 (2016) 1 - p. 115-122 , 2016

Link: https://doi.org/10.1038/..

11

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in re..:

Chng, W-J ; Goldschmidt, H ; Dimopoulos, M A...
Leukemia. 31 (2016) 6 - p. 1368-1374 , 2016

Link: https://doi.org/10.1038/..

12

A randomized phase III study of carfilzomib vs low-dose cor..:

Hájek, R ; Masszi, T ; Petrucci, M T...
Leukemia. 31 (2016) 1 - p. 107-114 , 2016

Link: https://doi.org/10.1038/..

13

Scleredema associated with multiple myeloma or MGUS: treatm..:

Krejci, M. ; Adam, Z. ; Pour, L....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e207 , 2015

Link: https://doi.org/10.1016/..

14

The Significance of Hevylite Test for Determination of Prog..:

Maisnar, V. ; Pour, L. ; Pika, T....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e120 , 2015

Link: https://doi.org/10.1016/..

15

P0090 Comparison of fine needle aspiration, Touch Print, an..:

Ahmadinejad, M. ; Pour, A.A. ; Amiri, Z.
European Journal of Cancer. 50 (2014) - p. e34-e35 , 2014

Link: https://doi.org/10.1016/..